TD Waterhouse Canada’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$993 Hold
232
﹤0.01% 2198
2026
Q1
$814 Hold
232
﹤0.01% 2116
2025
Q4
$561 Hold
232
﹤0.01% 1904
2025
Q3
$443 Hold
232
﹤0.01% 1941
2025
Q2
$432 Hold
232
﹤0.01% 1862
2025
Q1
$394 Hold
232
﹤0.01% 1809
2024
Q4
$731 Hold
232
﹤0.01% 1804
2024
Q3
$455 Hold
232
﹤0.01% 1760
2024
Q2
$332 Buy
+232
New +$430 ﹤0.01% 1795
2024
Q1
Sell
-232
Closed -$427 1969
2023
Q4
$427 Hold
232
﹤0.01% 1600
2023
Q3
$993 Hold
232
﹤0.01% 1555
2023
Q2
$1.58K Hold
232
﹤0.01% 1562
2023
Q1
$1.73K Hold
232
﹤0.01% 1534
2022
Q4
$2.85K Hold
232
﹤0.01% 1440
2022
Q3
$3.24K Hold
232
﹤0.01% 1435
2022
Q2
$2.96K Hold
232
﹤0.01% 1483
2022
Q1
$4K Hold
232
﹤0.01% 1491
2021
Q4
$5.68K Buy
+232
New +$5.83K ﹤0.01% 1435

Other funds holding WHWK

TD Waterhouse Canada's WHWK Position: Q2 2026 in Review

TD Waterhouse Canada held its Whitehawk Therapeutics (WHWK) position steady in Q2 2026 at 232 shares worth $993. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

TD Waterhouse Canada first reported a position in WHWK in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.68K in Q4 2021. 8 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • TD Waterhouse Canada held 232 shares of Whitehawk Therapeutics worth $993 as of Q2 2026.
  • TD Waterhouse Canada left its Whitehawk Therapeutics share count unchanged in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2198 holding.
  • TD Waterhouse Canada first reported a position in Whitehawk Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Whitehawk Therapeutics position peaked at $5.68K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.